Home > Clinical Trials

Saved trials

Completed
NCT00986154
Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study).
8,292 Enrollment(s)
407 Study location(s)
Interventional (Phase III)
Venous Thromboembolism
Deep Vein Thrombosis (DVT)
Pulmonary Embolism (PE)
Thromboembolism
Venous Thrombosis
Completed
NCT00781391
Global Study to Assess the Safety and Effectiveness of Edoxaban (DU-176b) vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation
21,105 Enrollment(s)
0 Study location(s)
Interventional (Phase III)
Stroke
Atrial Fibrillation
Embolism
Completed
NCT03254147
Medical Need of OAC Reversal
53,969 Enrollment(s)
1 Study location(s)
Observational
Atrial Fibrillation
Completed
NCT01959451
Testing Responsiveness to Platelet Inhibition on Chronic Antiplatelet Treatment For Acute Coronary Syndromes Trial
2,600 Enrollment(s)
33 Study location(s)
Interventional (Phase IV)
Acute Coronary Syndrome
Completed
NCT01802775
Edoxaban in Peripheral Arterial Disease
203 Enrollment(s)
1 Study location(s)
Interventional (Phase II)
Peripheral Arterial Disease
Completed
NCT01662908
A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis
85 Enrollment(s)
0 Study location(s)
Interventional (Phase II)
Deep Vein Thrombosis
Venous Thrombosis
Completed
NCT00806624
DU-176b Phase 2 Dose Finding Study in Subjects With Non-valvular Atrial Fibrillation
234 Enrollment(s)
0 Study location(s)
Interventional (Phase II)
Atrial Fibrillation
Stroke
Completed
NCT00504556
A Study to Assess the Safety of a Potential New Drug in Comparison to the Standard Practice of Dosing With Warfarin for Non-valvular Atrial Fibrillation
1,146 Enrollment(s)
0 Study location(s)
Interventional (Phase II)
Atrial Fibrillation
Thromboembolism